Healthcare Intelligence
Pharma - Drug Safety & Pharmacovigilance
Real-time intelligence, expert analysis, and verified research for the Pharma - Drug Safety & Pharmacovigilance industry. Stay ahead in 3 minutes a day.
Stay ahead of Pharma - Drug Safety & Pharmacovigilance in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
FDA: No Child Deaths Definitively Linked to COVID Vaccines
FDA analysis of 96 child death reports found no cases certain to be linked to COVID vaccination, contradicting earlier claims.
Read full articleWegovy Linked to Rare Vision Loss Condition in FDA Safety Analysis
Study finds Wegovy has 75x higher odds of causing ischemic optic neuropathy, a condition that can cause sudden blindness.
Read full articleEli Lilly's Retatrutide Shows 30% Weight Loss but Common GI Side Effects
Phase 3 trial reveals triple-action obesity drug achieves near bariatric-level weight loss with nausea affecting up to 42% of patients.
Read full articleNew Anti-Clotting Drug Prevents Strokes Without Bleeding Risk
Asundexian reduced recurrent stroke risk by 26% in 12,327-patient trial without increasing major bleeding complications.
Read full articleThree Red Cross Volunteers Die from Suspected Ebola in DR Congo
WHO raises Ebola risk to 'very high' as outbreak driven by rare Bundibugyo virus spreads with 82 confirmed cases.
Read full articleFDA Updates Myocarditis Warning Labels on COVID Vaccines
FDA instructs Pfizer and Moderna to update vaccine labels about myocarditis risk, particularly in teen boys and young men.
Read full articleGender Differences Found in GLP-1 Drug Vision Loss Risk
Men taking Wegovy face 100x higher ION risk while women show strongest signal with Ozempic, per FDA adverse event analysis.
Read full articleFactor XIa Inhibitor Shows Promise in Stroke Prevention Trial
First completed Phase 3 trial of Factor XIa inhibitor demonstrates safer anti-clotting approach with 31% reduction in fatal strokes.
Read full articleFDA: No Child Deaths Definitively Linked to COVID Vaccines
FDA analysis of 96 child death reports found no cases certain to be linked to COVID vaccination, contradicting earlier claims.
Read full articleWegovy Linked to Rare Vision Loss Condition in FDA Safety Analysis
Study finds Wegovy has 75x higher odds of causing ischemic optic neuropathy, a condition that can cause sudden blindness.
Read full articleEli Lilly's Retatrutide Shows 30% Weight Loss but Common GI Side Effects
Phase 3 trial reveals triple-action obesity drug achieves near bariatric-level weight loss with nausea affecting up to 42% of patients.
Read full articleNew Anti-Clotting Drug Prevents Strokes Without Bleeding Risk
Asundexian reduced recurrent stroke risk by 26% in 12,327-patient trial without increasing major bleeding complications.
Read full articleThree Red Cross Volunteers Die from Suspected Ebola in DR Congo
WHO raises Ebola risk to 'very high' as outbreak driven by rare Bundibugyo virus spreads with 82 confirmed cases.
Read full articleFDA Updates Myocarditis Warning Labels on COVID Vaccines
FDA instructs Pfizer and Moderna to update vaccine labels about myocarditis risk, particularly in teen boys and young men.
Read full articleGender Differences Found in GLP-1 Drug Vision Loss Risk
Men taking Wegovy face 100x higher ION risk while women show strongest signal with Ozempic, per FDA adverse event analysis.
Read full articleFactor XIa Inhibitor Shows Promise in Stroke Prevention Trial
First completed Phase 3 trial of Factor XIa inhibitor demonstrates safer anti-clotting approach with 31% reduction in fatal strokes.
Read full articleStay ahead of Pharma - Drug Safety & Pharmacovigilance in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.